source
- Anaconda Biomed snares $56M in funding for endovascular techMedtech startup Anaconda Biomed has hauled in $53 million to help finish off work on a pivotal trial for its endovascular project.
- Boehringer Ingelheim partners with Envisagenics on $1 billion AI-driven oncology collaborationBoehringer Ingelheim and AI drug discovery firm Envisagenics have signed a potential $1 billion multi‑year agreement to validate tumor‑specific targets. The deal will see Boehringer use Envisagenic…